Skip to main content

Table 3 SUVmeans in background organs scanned with FDOPA-L and FDOPA-H in organs. Data are presented in medians plus interquartile ranges

From: The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors

Background region

SUVmean [18]FFDOPA-L

SUVmean [18]FFDOPA-H

p value

Effect size r

Striatum

1.21 (1.11–1.36)

1.36 (1.09–1.49)

0.011

− 0.36a

Heart

1.52 (1.25–1.77)

1.62 (1.39–1.85)

0.006

− 0.39a

Aorta

1.12 (1.04–1.22)

1.18 (1.05–1.31)

0.004

− 0.40a

Liver

1.64 (1.45–1.74)

1.67 (1.48–1.86)

0.068

− 0.26a

Gallbladder

2.65 (1–50-4.31)

2.90(0.96–4.17)

0.540

− 0.09b

Pancreas (head)

1.66 (1.39–1.94)

1.59 (1.34–1.89)

0.255

− 0.17b

Pancreas (body)

1.47 (1.19–1.75)

1.53 (1.32–1.87)

0.174

− 0.20a

Pancreas (tail)

1.46 (1.22–1.73)

1.55 (1.34–1.84)

0.010

− 0.38a

Left kidney

2.73 (2.36–3.04)

2.83 (2.55–3.39)

0.028

− 0.31a

Right kidney

2.74 (2.45–3.02)

2.99 (2.70–3.67)

0.000*

− 0.59a

Left adrenal gland

2.12 (1.86–2.72)

2.50 (1.98–3.26)

0.000*

− 0.52a

Right adrenal gland

2.34 (1.83–3.05)

2.49 (2.15–3.30)

0.005

− 0.41a

  1. *Considered significant
  2. aBased on negative ranks
  3. bBased on positive ranks